Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
about
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response.Hedgehog signaling in prostate cancer and its therapeutic implicationTargeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.
P2860
Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Radiosensitization of prostate ...... t cellular senescence pathway.
@ast
Radiosensitization of prostate ...... t cellular senescence pathway.
@en
type
label
Radiosensitization of prostate ...... t cellular senescence pathway.
@ast
Radiosensitization of prostate ...... t cellular senescence pathway.
@en
prefLabel
Radiosensitization of prostate ...... t cellular senescence pathway.
@ast
Radiosensitization of prostate ...... t cellular senescence pathway.
@en
P2860
P356
P1476
Radiosensitization of prostate ...... nt cellular senescence pathway
@en
P2093
David M Terrian
James A McCubrey
P2860
P304
P356
10.4161/CBT.6.8.4544
P577
2007-08-05T00:00:00Z